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Hossein Najmabadi1, Mohamad H. Kariminejad1, Olivier M. Vanakker4, Mohammad J. Hosen4,
Fransiska Malfait4, Daniela Quaglino5, Ralph J. Florijn6, Arthur A.B. Bergen6,7,8 and Raoul C. Hennekam7,9
Gamma-glutamyl carboxylase (GGCX) mutations have been reported in patients with a pseudoxanthoma
elasticum (PXE)–like phenotype, loose redundant skin, and multiple vitamin K–dependent coagulation factor
deficiencies. We report on the clinical findings and molecular results in 13 affected members of two families who
had a uniform phenotype consisting of (PXE)-like skin manifestations in the neck and trunk, loose sagging skin of
the trunk and upper limbs, and retinitis pigmentosa confirmed by electroretinographies in 10 affected
individuals. There were no coagulation abnormalities. Molecular investigations of the ATP-binding cassette
subfamily C member 6 did not yield causative mutations. All 13 affected family members were found to be
homozygous for the splice-site mutation c.373þ 3G4T in the GGCX gene. All tested parents were heterozygous
for the mutation, and healthy siblings were either heterozygous or had the wild type. We suggest that the present
patients represent a hitherto unreported phenotype associated with GGCX mutations. Digenic inheritance has
been suggested to explain the variability in phenotype in GGCX mutation carriers. Consequently, the present
phenotype may not be explained only by the GGCX mutations only but may be influenced by variants in other
genes or epigenetic and environmental factors.
Journal of Investigative Dermatology (2014) 134, 2331–2338; doi:10.1038/jid.2014.191; published online 15 May 2014
INTRODUCTION
Pseudoxanthoma elasticum (PXE; MIM 264800) is an auto-
somal recessive condition with manifestations in the skin
(yellowish papules in the neck and flexural areas; inelastic
and leathery skin), the eyes (angioid streaks; retinal neovascu-
larization, exudations, and hemorrhages), and the cardiovas-
cular system (occlusive arterial disease). The clinical features
are secondary to ectopic mineralization of the extracellular
matrix, particularly the elastic fibers, but the exact pathophy-
siological mechanisms still remain unclear (Uitto et al., 2010).
PXE is caused by mutations in the ABCC6 gene (ATP-binding
cassette subfamily C member 6) (Le Saux and Urban, 1999;
Bergen et al., 2000; Ringfeil et al., 2001; Miksch et al., 2005;
Pfendner et al., 2007), encoding an efflux pump that is mainly
expressed in the liver and at lower levels in the proximal
tubules of the kidney but hardly, if at all, in the clinically
affected tissues (Belinsky and Kruh, 1999; Scheffer et al.,
2002; Jiang et al., 2006). In view of the association of PXE with
ABCC6 efflux transport, it has been hypothesized that PXE is a
systemic metabolic disease caused by lack or accumulation of
molecules interacting with the synthesis, turnover, and/or
maintenance of the extracellular matrix in the bloodstream
(Li et al., 2009b).
PXE(-like) skin manifestations have been reported to co-
occur with loose, redundant skin and a deficiency of vitamin
K-dependent clotting factors (MacMillan and Vickers 1971;
Rongioletti et al., 1989; Le Corvaisier-Pieto et al., 1996).
Subsequently, Vanakker et al., 2007 reported six unrelated
patients with severe PXE-like skin manifestations, cutis
laxa, and relatively mild angioid streaks. Ultrastructurally,
fragmentation and calcification of elastic fibers in the reticular
dermis were observed, which are commonly seen in PXE,
although subtle differences with respect to the localization of
the mineral precipitates and the structure of the elastic fiber
network could be observed. All six patients had decreased
vitamin K-dependent coagulation factor activity. Molecular
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studies showed homozygous or compound heterozygous
mutations in gamma-glutamyl carboxylase (GGCX) in three
of the six patients and in one other patient, previously reported
by Le Corvaisier-Pieto et al. (1996). In two other patients only
a single GGCX mutation could be detected.
GGCX encodes a gamma-carboxylase, which catalyzes
gamma-glutamyl carboxylation of coagulation factors as well
as of matrix gla protein (MGP). The carboxylated form of MGP
serves as a systemic inhibitor of pathologic mineralization.
Previously, hereditary deficiency of vitamin K-dependent
procoagulants were reported in individuals with GGCX muta-
tions (Brenner et al., 1990, 1998; Rost et al., 2004).
GCCX missense mutations, together with a recurrent
ABCC6 nonsense mutation, (p.R1141X) were identified in a
mother and maternal aunt of two sibs who had a PXE-like
phenotype and vitamin K-dependent coagulation factor defi-
ciency, whereas the mother and aunt had only a PXE-like
phenotype (Li et al., 2009a), suggesting digenic inheri-
tance. The sibs themselves had compound heterozygous
GGCX mutations (p.R83W; p.Q374X). The authors suggested
that the loss-of-function ABCC6 mutations caused reduced
vitamin K-dependent gamma-glutamyl carboxylation of MGP,
which in turn resulted in connective tissue mineralization
(Li et al., 2009a).
Vanakker et al. (2010) compared various forms of vitamin
K-dependent proteins in the serum, plasma, and dermal tissues
in patients with GGCX mutations and in patients with ABCC6
mutations using conformation-specific antibodies and vitamin
K levels in serum. GGCX patients showed accumulation of
uncarboxylated Gla proteins, MGP, and osteocalcin in the
plasma, serum, and dermis, and normal vitamin K levels.
ABCC6 patients had similarly elevated Gla protein levels but a
significant decrease in serum vitamin K levels. The authors
concluded that the ectopic mineralization in PXE and PXE-like
patients is caused by deficient carboxylation of vitamin
K-dependent inhibitors of calcification. Mutations in GGCX
are the cause of this deficiency in PXE-like patients, whereas
in ABBC6 patients deficiency of the carboxylation co-factor
vitamin K is the cause of the decreased activity of calcification
inhibitors. Evidence from studies in abcc6  / mice suggests
that neither Vitamin K nor Ca2þ dietary intake has a role in
the progression of PXE. Instead, intake of high Mg2þ
apparently slows down the progression of PXE (Gorgels
et al., 2010; Li and Uitto, 2010).
Here we present two families with a total of 14 affected
members, 13 of whom were examined, showing skin mani-
festations resembling PXE in the neck and flexural areas, loose,
sagging skin of the trunk, and retinitis pigmentosa (RP), who
were found to harbor homozygous GGCX mutations.
RESULTS
Clinical reports
Family 1. The proband (Figure 1) V12 is the first-born son of
first-cousin parents. Pregnancy, delivery, and early physical and
psychomotor development were uneventful. The parents noticed
progressive reduced vision, especially at night, from the age of 3.5
years onward; otherwise he had no physical complaints. He
followed a normal cognitive development for a visually handi-
capped individual. At 12 years, yellowish papules were noted at
the back and sides of the neck and in the chest and flexural areas,
and unusually loose skin on the trunk. The loose skin gradually
became more marked and also evident on the upper limbs. He
was referred because of his disturbed vision and similar problems
within the family. Physical examination did not show significant
morphological abnormalities. Loose sagging skin was evident on
the trunk and upper limbs (Figure 2a and b), and characteristics
resembling PXE in the neck and flexural regions (Figure 2c and d).
Fundoscopy showed intra-retinal clumps of black pigment,
markedly attenuated retinal vessels, loss of retinal pigment
epithelium, and pallor of the optic nerve, all of which are findings
commonly seen in RP (Figure 2e). Ocular findings associated with
PXE, such as angioid streaks, loss of central vision, exudation, and
hemorrhage, were absent. An electroretinography confirmed the
presence of RP (Supplementary Figure S1 online). Echocardio-
graphy yielded normal results. Additional signs and symptoms
that can occur in PXE, such as gastrointestinal bleeding, inter-
mittent claudication, loss of peripheral pulses, renovascular
hypertension, angina pectoris, and myocardial infarctions, were
searched for in the proband and found to be absent. Detailed
clotting studies failed to show abnormalities (Supplementary
Table S1 online).
Family 2. The proband of family 1 originated from a small
village from the north of Iran with 4,000 inhabitants. He informed
us that there were nine other affected members in his family and
four others from another family living in the same village
(Figure 1). All other 10 affected members from family 1 and three
out of four affected members from family 2 were available for
evaluation. The phenotype in all other affected individuals was
very similar, only varying in terms of time of onset of ocular and
skin involvement (Supplementary Table S1 online). Electroretino-
graphy examination could be performed in 10 patients and
showed nondetectable rod responses or rod responses with
reduced amplitude and prolonged implicit time confirming the
diagnosis of RP (Supplementary Table S1 online). Fundoscopy
was performed on 16 members, nine affected and seven unaf-
fected members, which showed no manifestations of PXE but did
show the same RP findings as in the proband in all nine
investigated affected individuals. Unaffected individuals did not
show any ocular findings associated with RP (Supplementary
Table S2 online). Clotting studies performed on 10 affected
individuals yielded normal values as well. None of the patients
reported any abnormal bleeding tendency. Parents and healthy
siblings were examined for dermatological and ocular problems,
specifically a PXE phenotype, loose sagging skin, and reduced
night and peripheral vision, which were normal in all 17 patients.
Histological studies
Light microscopic and electron microscopic evaluation of a
full-thickness skin biopsy taken from lesional skin in the upper
anterior thigh showed important fragmentation and fragility of
the specimens in both families (Figure 3). The presence of thin
and fragmented elastic fibers was observed in the superficial,
mid-, and reticular dermis, with limited mineralization in
these areas. In the very deep dermis, elastic fibers were found
to be heavily mineralized, with fine mineral precipitates
within the elastic fibers. Collagen fibers were small in some
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areas and fusion of collagen fibrils was rarely seen; other
ultrastructural abnormalities were not observed. Fibroblasts
only rarely showed features such as dilatation of the endo-
plasmic reticulum or large cells described in classical PXE.
(Figure 3). Immunohistochemistry with confirmation-specific
antibodies against uncarboxylated MGP demonstrates positive
labeling compared with control tissue (Figure 4). The staining
was clumped, resembling what is observed in the PXE-like
phenotype with coagulation factor deficiency, albeit less
abundant in our families.
Molecular analyses
Sequences of ABCC6 in the proband and member IV1 of
family 2 (Figure 1) were of wild type. Exon 23–29 deletion and
other homozygous deletions in ABCC6 were excluded by
exon-specific amplifications and sequencing. A pathogenic
sequence change was found in GGCX in both individuals: a
novel splice-site change c.373þ3G4T was present homo-
zygously (Figure 5a). We subsequently screened all 30 avail-
able family members and found that the GGCX sequence
change fully co-segregated with the PXE-like phenotype as a
recessive trait.
Alamut software analysis of this variant showed the
sequence change to be rare. Three out of five splice-site
prediction programs predicted significant aberrant splice
patterns for this mutation (Table 1). The c.373þ3G4T
sequence change causes a skip of exon 3 in the GGCX
mRNA, and at a protein level results in a deletion of 53 amino
acids (p.Phe73_Gly125del) (Figure5b).
The c.373þ 3G4T sequence change in GGCX was not
present in human healthy control WWW genome sequence
databases (the 1000 genome project (1000 genomes.org) and
Exome variant server (http://evs.gs.washington.edu/EVS)).
DISCUSSION
Here we describe two large families with 14 affected indivi-
duals from a small village from the north of Iran with skin
manifestations on the back and side of the neck resembling
PXE, cutis laxa involving the trunk and upper limbs, and RP.
The phenotype in the patients showed hardly any variation.
The findings in 13 members of the present families are
summarized in Supplementary Table S1 online and compared
with similar literature reports in Table 2. Table 2 shows that
none of the previously published families show the same
combination of signs and symptoms. The skin findings in the
present patients are very similar with previously reported cases
of PXE-like phenotype with GGCX mutations. The degree of
sagging, loose skin is more severe in the present patients and
in other patients with GGCX mutations compared with that in
patients with classical PXE caused by ABCC6 mutations. If PXE
patients have sagging and loose skin it is typically located in
the flexural regions, but in GGCX-mutated patients this is
more widespread and includes the trunk and upper limbs,
leaving the face and distal limbs uninvolved. The main
differences between the present patients and previously
reported cases with GGCX mutations are the histological
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Figure 1. Pedigrees and clinical characteristics of the two families. (a, b) Affected individuals are indicated with black symbols.
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Although fragmentation of the elastic fibers could be
observed throughout the dermis, mineralization of the fibers
was most prominently present in the deepest layers of the
dermis. This localization is very unusual for classical PXE or
for the PXE-like phenotype with associated coagulopathy.
Unlike in the latter disorders, the morphology of the fibroblasts
was not significantly changed in the present families. The
remarkable histological features underline the importance of
sufficient depth of skin biopsy specimens when evaluating
patients with a PXE-related phenotype.
Clinically, all patients reported in this study had poor night
vision and reduced peripheral vision. The RP was confirmed
by electroretinography in all 10 tested patients (Supplementary
Table S1 online). None had eye findings resembling PXE.
Four out of 13 previously reported patients with GGCX
mutations had ocular abnormalities, including angioid streaks,
but none had RP.
None of the present patients had abnormal bleeding
tendencies, and coagulopathy tests performed on all 10 tested
patients yielded normal results (Supplementary Table SI
online). Such bleeding tendencies (meningeal hemorrhages,
postpartum hemorrhage, hematemesis, spontaneous gingival
bleeding, and severe vaginal hemorrhages) have been
reported in other GGCX-mutated patients who were found
to have a deficiency of vitamin K-dependent coagulation
factors (Vanakker et al., 2007). The reason for the absence
of bleeding diathesis in our families is currently unclear,
similar to the as-yet-unknown explanation why some
patients with GGCX mutations develop a skin and eye
phenotype and others do not. A splice-site mutation leading
to the deletion of exon 3 of GGCX has been previously
described in a patient with isolated hereditary vitamin K com-
bined clotting factors deficiency, in whom it was compound






Figure 2. Clinical findings and fundus image of proband. (a, b) Excessive skin folds and leathery texture mostly prominent in the trunk. (c, d) Note yellowish
papules and depressed dots in the neck. (e) Fundus of affected individual V12 of family 1 (Figure 1) showing characteristics of retinitis pigmentosa (RP).
A Kariminejad et al.
RP, Cutis Laxa, and PXE-Like Phenotype
2334 Journal of Investigative Dermatology (2014), Volume 134
2004). Although we cannot exclude that the phenotypic effect
may differ based on the position of each mutation or that the
cumulative effect of two splice-site mutations is different
compared with a compound heterozygous splice site and
missense variant, no evidence is currently available to
substantiate these hypotheses. In addition, the influence of
modifier genes on the phenotype cannot be excluded. Besides
the two reported phenotypes associated with mutations in
GGCX—isolated hereditary vitamin K combined clotting
factors deficiency and PXE-like phenotype with multiple
coagulation factor deficiency—we propose that GGCX muta-
tions can also be associated with a PXE-like phenotype and
with RP, without coagulopathy. We cannot exclude with
certainty the theory that in the present two families the RP
and PXE-like phenotype are two separate entities segregating
by coincidence together. Co-segregation of two conditions in
at least 13 individuals and absence of isolated occurrence of
either of the two conditions in any other family member make
this hypothesis extremely unlikely; only in case of linkage
disequilibrium may this happen by coincidence. There is,
however, no gene known to cause RP located within 10Mb of
GGCX, which makes this also highly unlikely. In addition, the
absence of vitamin K-dependent clotting factor deficiency and
the unique histological features suggest this to be a different
GGCX-related phenotype. Although we have no definite
explanation on how GGCX malfunctioning can lead to RP,
it is interesting that one of the Gla proteins, Gas6, is known to
be involved in a recessive form of RP due to mutations in
MERTK (Hafizi and Dahlba¨ck 2006; Ksantini et al., 2012).
MERTK encodes a specific receptor tyrosine kinase, which on
the apical surface of the retinal pigment epithelium interacts
with the shed tips of the photoreceptor outer segments via a
signaling molecule, Gas6. One could hypothesize that, if
MERTK mutations cause RP, than a decreased function of its
signaling molecule Gas6 due to defective GGCX function may


















Figure 3. Histology of skin lesions using light and electron microscopy. (a) Full-thickness overview of the affected skin shows thin and fragmented elastic fibers in
areas 1 through 4. Only in area 5 can mineralization of the fragmented elastic fibers be assumed. This is further documented using Alizarin red staining (b; original
magnification  20), showing extensive labeling in the deeper dermis, whereas only limited mineralization is observed in the reticular and mid-dermis. High-
resolution electron microscopy of the deeper dermis shows mineralization in the core and periphery of the affected elastic fibers (c–e; asterisks). Collagen fibers
show some variation, some being small, but no other abnormalities. Scale bar¼1mm.
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specific, this implies that such a hypothesis can only be
investigated further on retinal tissue, which is for obvious
reasons not available from these patients (Healy et al., 2001).
Recently, digenic inheritance of a PXE-like phenotype
including loose sagging skin but without coagulopathy was
suggested by Li et al., 2009a, caused by mutations in both
a b c
d e
Figure 4. Immunohistochemistry for uncarboxylated (uc) matrix gla protein (MGP). (a) Alizarin red staining of the examined skin fragments. All tissues were
fragile and heavily fragmented, probably because of the disease itself. (b) Staining for ucMGP shows positive labeling compared with a negative control
(c). The staining, which is clumped (d), resembles staining of ucMGP in the pseudoxanthoma elasticum (PXE)-like syndrome with coagulation factor deficiency
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c
Figure 5. Gamma-glutamyl carboxylase (GGCX) (accession number NM_000821.4) exons were sequenced in DNA samples of this family. (a) Chromatograms
of the identified sequence change c.373þ3 G4T are shown for a homozygous, heterozygous, and consensus sequence. The lower bar schematically shows
the exon/intron structure of GGCX exon 3. (b) The c.373þ 3G4T sequence change causing a skip of exon 3 in the GGCX mRNA. (b) Wild-type cDNA
sequence; (c) patient cDNA sequence.
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GGCX and ABCC6. Similar compound heterozygous ABCC6
mutations and a gain-of-function GGCX variant have been
reported by Vanakker et al. (2011). The identified mutations
could not fully explain the clinical and biochemical findings
in their patient and they suggested that variants in other genes
involved in calcium homeostasis may have a role in the
atypical presentation of this patient. Similarly, the present
phenotype may not be explained by the GGCX mutations
alone but may also be influenced by variants in other genes.
We have excluded an influence by ABCC6 mutations.
Epigenetic and also environmental influences cannot be
excluded with certainty either.
MATERIALS AND METHODS
Approval
Approval was obtained from the Medical Ethics Committee (Pathology
and Genetics Center, Tehran). Written informed consent was obtained
from all study participants. The study was conducted in compliance
with the guidelines described in the Declaration of Helsinki.
Histological studies
One patient of each family had a full-thickness skin biopsy taken of a
skin lesion. Biopsies were evaluated with light microscopy using
hematoxylin and eosin, van Giesson (elastin), Alizarin Red (calcium),
and a mAb against ucMGP (EnzoLife Sciences, Antwerp, Belgium).
For immunohistochemical analysis, sections were heated in 0.2%
citric acid at pH 6.0, washed with phosphate-buffered saline, and
incubated with the primary antibody. The antibody was diluted in
blocking reagent (Roche Diagnostics, Mannheim, Germany). Nega-
tive controls were obtained by omitting the primary antibody.
Biotinylated sheep anti-mouse IgG (Amersham Biosciences, Little
Chalfont, UK) was used as a secondary antibody (1 hour at room
temperature), followed by incubation with the avidin-linked alkaline
phosphatase complex (Dako, Golstrup, Denmark); staining was
performed with the AEC revelation kit (brown stain; Dako). Sections
were counterstained with hematoxylin and mounted with coverslips.
For electron microscopy, skin biopsy fragments were immediately
fixed in 3% glutaraldehyde in Tyrode’s saline (pH 7.2) for 2–4hours
at room temperature, washed in saline, postfixed in 1% osmium
tetroxide in the same buffer for 1 hour, dehydrated in ethanol and
propylene oxide, and embedded in spurr resin. Semithin sections
were stained with 1% toluidine blue and observed by light micro-
scopy. Thin sections were stained with 1% uranyl acetate in 50%
ethanol and lead citrate and observed with a Jeol EM1200 electron
microscope (magnification  10,000).
Molecular analyses
Genomic DNA was isolated from peripheral blood samples according
to a standard procedure (Miller et al. 1988). The entire coding region
and adjacent splice-site sequences were systematically screened in
ABCC6 (NM_001171.5) and GGCX_(NM_000821.4) by Sanger
Table 1. Donor-splice prediction scores for the
gamma-glutamyl carboxylase c.373þ 3 G4T sequence













SSF (0–100) X70 77.53 72.02 ( 7.1%)
MaxEnt (0–12) X0 6.74 —
NNSPLICE (0–1) X0.4 0.92 —
Genesplicer (0–15) X0 0.51 —
HSF (0–100) X60 85.20 78.11 ( 8.3%)
The threshold values are according to the default settings of that program.
















Author 1 2 3 4 5 6 7 8 9 10 11 12 13 14 N¼13
Gender F F M M F F F F F M F F F F 8M/5F
Age 24 24 33 40 46 47 67 32 46 44 16 19 40 40 31.8 (16–52)
Age at onset of skin signs (years) P P P 16 18 13 3 18 NA NA 10 P NA NA 13.5 (10–25)
Cutis laxa þ þ þ þ þ þ þ þ þ þ þ þ þ þ 13/13
Pseudoxanthoma elasticum-like
signs
þ þ þ þ  þ þ þ þ þ   þ þ 13/13
Retinitis pigmentosa               10/10
Other eye findings     AS AS AS AS       11/13 Strabismus
Abnormal bleeding tendency þ þ  þ   þ  þ  þ þ   0/13
Clotting deficiency þ þ þ þ þ þ þ þ þ þ þ þ   0/10
ATP-binding cassette subfamily
C member 6 mutation(s)
NA NA NA     NA NA   þ / þ / 0/13
Gamma-glutamyl carboxylase
mutation(s)
NA NA NA  þ /þ  þ / þ / þ /þ þ /þ þ /þ þ /þ þ / þ / 13/13
Abbreviations: AS, angioid streaks; F, female; M, male; NA, not available; P, puberty.
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sequencing (primer sequences are available upon request). Exon
23–29 deletion and other homozygous deletions were excluded by
exon-specific amplifications and sequencing. Sequences were ana-
lyzed using Codoncode aligner (Codon Code Corporation). The
potential pathogenicity of unreported changes was evaluated by
segregation analysis of the variant in the families, using the Alamut
version 2.1 software mutation assignment package (Interactive Bio-
software, Rouen, France) and by screening of the known variant
WWW databases. Blood was collected in PAX gene tubes (QIAGEN,
Venlo, The Netherlands) and total RNA was isolated according
to the manufacturer’s protocol. cDNA was then synthesized using
polyT primer and superscript III reverse transcriptase (Invitrogen,
Carlsbad, CA) according to the standard procedure. cDNA frag-
ments were amplified using M13-tailed primers specific for exon 2
(5’-tgtaaaacgacggccagtAGGCAGGACAGCCGAATAG-3’) and exon 7
(5’-caggaaacagctatgaccAAAGCTGGGAATTCATGCAG-3’) and ampli-
fied fragments were sequenced.
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